1 Answers
Dr. Shoyeb
এমবিবিএস
,
পিজিটি(মেডিসিন)
,
সিসিডি(বারডেম)
,
সিএমইউ
Lenvatinib is a kinase inhibitor that is indicated:
- For the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).
- In combination with everolimus, for the treatment of patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy.
- For the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).
Lenvanix Capsule সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Lenvanix
4400 views
Answered